{
    "nctId": "NCT03992664",
    "briefTitle": "Education Intervention in Patients With Rash Due to Epidermal Growth Factor Receptor (EGFR) Treatment.",
    "officialTitle": "Effectiveness of Educational Intervention for Patients That Receive Treatment With EGFRI",
    "overallStatus": "UNKNOWN",
    "conditions": "Consent Form, Lung Cancer, Colon Cancer, Pancreas Cancer, Head and Neck Cancer, Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 40,
    "primaryOutcomeMeasure": "Through a randomized feasibility clinical trial to investigate the effectiveness of an educational intervention in conjunction with routine management of rash in patients receiving EGFRI therapy.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients who take EGFR therapy for the first time.\n* Classify at 0 or 1 according to WHO performance status.\n\nExclusion Criteria:\n\n* Patients with previous exposure to EGFR treatment.\n* People already suffering from rash.\n* People already suffering with other dermatological problems, eg psoriasis.\n* People already taking part in any other study.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}